Local Excision After Preoperative Chemoradiotherapy for Rectal Cancer: Results of a Multicenter Phase II Clinical Trial

被引:145
|
作者
Pucciarelli, Salvatore t [1 ]
De Paoli, Antonino [2 ]
Guerrieri, Mario [3 ]
La Torre, Giuseppe [4 ]
Maretto, Isacco [1 ]
De Marchi, Francesco [5 ]
Mantello, Giovanna [6 ]
Gambacorta, Maria Antonietta [7 ]
Canzonieri, Vincenzo [8 ]
Nitti, Donato [1 ]
Valentini, Vincenzo [7 ]
Coco, Claudio [9 ]
机构
[1] Univ Padua, Dept Surg, Oncol & Gastroenterol, I-35128 Padua, Italy
[2] NCI, Dept Radiat Oncol, Aviano, Italy
[3] Univ Politecn Marche, Gen Surg, Ancona, Italy
[4] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy
[5] NCI, Dept Surg Oncol, Aviano, Italy
[6] State Hosp, Dept Radiotherapy, Ancona, Italy
[7] Univ Cattolica Sacro Cuore, Dept Radiotherapy, Rome, Italy
[8] NCI, Dept Pathol, Aviano, Italy
[9] Univ Cattolica Sacro Cuore, Dept Surg Sci, Rome, Italy
关键词
Chemoradiotherapy; Local control; Local excision; Rectal cancer; POSITIVE COLON-CANCER; ADJUVANT CHEMOTHERAPY; FLUOROURACIL; SURVIVAL;
D O I
10.1097/DCR.0b013e3182a2303e
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: Transanal local excision has been suggested as an attractive approach for patients with rectal cancer who show a major clinical response after preoperative chemoradiotherapy. OBJECTIVE: To evaluate the impact of transanal local excision on the local recurrence of rectal cancer in patients who had a major clinical response after preoperative chemoradiotherapy. DESIGN: Sequential 2-stage phase II study for early efficacy. SETTING: Multicenter study. PATIENTS: Patients with clinical T3 or low-lying T2 rectal adenocarcinoma that showed a major clinical response after a preoperative chemoradiotherapy. Eligible patients underwent a full-thickness transanal local excision. According to their histopathology, the patients staged as ypT0-1 were observed, while the remaining patients were recommended to undergo a subsequent total mesorectal excision. MAIN OUTCOME MEASURES: A local recurrence rate of <= 5% was set as a successful rate for stopping the trial early after the first stage. RESULTS: The study group included 63 patients. Before chemoradiotherapy, patients were staged as clinical T3 (n = 42) and T2 (n = 21). After the local excision, 43 patients fulfilled the criteria to be observed with no further treatment. Nine of the remaining 20 patients for whom a subsequent total mesorectal excision was recommended refused surgery. Two of these patients who refused surgery had intraluminal local recurrence; both had a ypT2 tumor and underwent salvage surgery. The estimated cumulative 3-year overall survival, disease-free survival and local disease-free survival were 91.5% (95% CI: 75.9-97.2), 91.0% (95% CI: 77.0-96.6) and 96.9% (95% CI: 80.3-99.5), respectively. LIMITATIONS: The time of follow-up is still short and the sample size is limited. CONCLUSIONS: Our data suggest that local excision is a good option for patients with a major clinical response after chemoradiotherapy. A longer period of follow-up is required to confirm these findings.
引用
收藏
页码:1349 / 1356
页数:8
相关论文
共 50 条
  • [1] Preoperative chemoradiotherapy for locally advanced rectal cancer: Multicenter phase II clinical trial.
    Hiratsuka, Takahiro
    Akagi, Tomonori
    Empuku, Shinichiro
    Nakajima, Kentaro
    Ueda, Yoshitake
    Tojigamori, Manabu
    Shiroshita, Hidefumi
    Etoh, Tsuyoshi
    Ninomiya, Shigeo
    Hiroishi, Kazuaki
    Yoshizumi, Fumitaka
    Takeuchi, Yu
    Sasaki, Atsushi
    Tahara, Koichiro
    Fujii, Kyuzo
    Shiromizu, Akio
    Ishikawa, Koichi
    Matsumoto, Toshifumi
    Bando, Toshio
    Inomata, Masafumi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Preoperative chemoradiotherapy in older patients with rectal Cancer: a multicenter phase II trial
    Liu, W.
    Tang, Y.
    Jin, J.
    Li, N.
    Wang, J.
    Cheng, Y.
    Wang, S.
    Li, Y.
    Wang, X.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S675 - S676
  • [3] LOCAL EXCISION AFTER PREOPERATIVE RADIOCHEMOTHERAPY FOR RECTAL CANCER: A MULTICENTER PHASE II CLINICAL TRIAL WITH A 3-YEAR FOLLOW-UP
    Pucciarelli, S.
    De Paoli, A.
    Guerrieri, M.
    La Torre, G.
    Maretto, I.
    De Marchi, F.
    Mantello, G.
    Gambacorta, M.
    Canzonieri, V.
    Nitti, D.
    Valentini, V.
    Coco, C.
    [J]. DISEASES OF THE COLON & RECTUM, 2013, 56 (04) : E92 - E92
  • [4] Multicenter clinical trial - preoperative chemoradiotherapy for locally advanced rectal cancer-
    Sugita, Satoshi
    Inomata, Masafumi
    Akagi, Tomonori
    Nakajima, Kentaro
    Ueda, Yoshitake
    Tojigamori, Manabu
    Shiroshita, Hidefumi
    Etoh, Tsuyoshi
    Shiraishi, Norio
    Kitano, Seigo
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 318 - 318
  • [5] Clinical Outcomes of Local Excision Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
    Lee, Nam Kwon
    Kim, Dae Yong
    Kim, Sun Young
    Oh, Jae Hwan
    Park, Won
    Choi, Doo Ho
    Nam, Taek-Keun
    Lee, Kyung-Ja
    [J]. CANCER RESEARCH AND TREATMENT, 2014, 46 (02): : 158 - 164
  • [6] Multicenter phase II trial of transanal total mesorectal excision for rectal cancer: preliminary results
    Patricia Sylla
    Dana Sands
    Alison Ricardo
    Antoinette Bonaccorso
    Alexandros Polydorides
    Mariana Berho
    John Marks
    Justin Maykel
    Karim Alavi
    Karen Zaghiyan
    Mark Whiteford
    Elisabeth Mclemore
    Sami Chadi
    Sherief F. Shawki
    Scott Steele
    Alessio Pigazzi
    Matthew Albert
    Teresa DeBeche-Adams
    Erin Moshier
    Steven D. Wexner
    [J]. Surgical Endoscopy, 2023, 37 : 9483 - 9508
  • [7] Multicenter phase II trial of transanal total mesorectal excision for rectal cancer: preliminary results
    Sylla, Patricia
    Sands, Dana
    Ricardo, Alison
    Bonaccorso, Antoinette
    Polydorides, Alexandros
    Berho, Mariana
    Marks, John
    Maykel, Justin
    Alavi, Karim
    Zaghiyan, Karen
    Whiteford, Mark
    Mclemore, Elisabeth
    Chadi, Sami
    Shawki, Sherief F.
    Steele, Scott
    Pigazzi, Alessio
    Albert, Matthew
    DeBeche-Adams, Teresa
    Moshier, Erin
    Wexner, Steven D.
    [J]. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2023, 37 (12): : 9483 - 9508
  • [8] Improving the local excision strategy for rectal cancer after chemoradiotherapy: Surgical and oncological results
    Meillat, Helene
    Weets, Victoria
    Saadoun, Jacques-Emmanuel
    Tyran, Marguerite
    Mitry, Emmanuel
    Illy, Mathias
    de Chaisemartin, Cecile
    Lelong, Bernard
    [J]. EJSO, 2024, 50 (11):
  • [9] Local failure after neoadjuvant treatment and local excision for rectal cancer: a multicenter LEADER trial
    Pucciarelli, S.
    De Paoli, A.
    Guerrieri, M.
    Valentini, V.
    Perin, A.
    De Marchi, F.
    Mantello, G.
    Canzonieri, V.
    Friso, M. L.
    Coco, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S193 - S194
  • [10] Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer
    Shin, Young Seob
    Yoon, Yong Sik
    Lim, Seok-Byung
    Yu, Chang Sik
    Kim, Tae Won
    Chang, Heung Moon
    Park, Jin-hong
    Do Ahn, Seung
    Lee, Sang-Wook
    Choi, Eun Kyung
    Kim, Jin Cheon
    Kim, Jong Hoon
    [J]. RADIATION ONCOLOGY JOURNAL, 2016, 34 (03): : 177 - 185